Archive for the ‘Activism’ Category

Why the FDA is Attacking NAC Supplements – TAKE ACTION

https://anh-usa.org/why-the-fda-is-attacking-nac-supplements/

Why the FDA is Attacking NAC Supplements?

JULY 15, 2021

N-acetyl-L-cysteine (NAC) has been on the market as a supplement for decades—why is the FDA attacking it now? Action Alert!

A few weeks ago, we told you about the FDA’s recent actions threatening NAC supplements—products which the FDA has allowed on the market for decades. The question is, why now, after all these years, is the FDA doing this? Digging a bit deeper, it seems obvious that the FDA is clearing the market of affordable NAC supplements in an effort to eliminate competition for NAC drugs that could be coming to market in the next few years. If our suspicions are correct, this would be another outrageous example of the FDA doing Big Pharma’s dirty work. We cannot let it happen.

To briefly recap how we got here: In a slew of warning letters sent last year, the FDA targeted a number of supplement companies marketing “unapproved” cures for hangovers—which the agency absurdly considers to be a “disease.” Some of these products contain NAC. In the letters to those companies, the FDA states that NAC does not meet the legal definition of a supplement because it was approved as a drug in 1963; according to federal law, any substance approved as a drug before it was sold as a supplement cannot be sold as a supplement. All of this means that the status of NAC as a supplement is currently in dispute.

So, why is the FDA threatening NAC now, during a pandemic when a new FDA commissioner hasn’t even been appointed? For starters, a drug company is investigating NAC as a treatment for a rare genetic disorder that damages the myelin sheath, which insulates nerve cells in the brain. The Phase 1 trial was completed in March 2020.

But that’s just the beginning. A search through the government’s clinical trials database shows considerable interest from the pharmaceutical industry in NAC. There are 17 trials looking at NAC, in both drug and supplement form, in the treatment of COVID. Additionally, there are over 50 trials looking at NAC for a variety of other conditions, including: autism spectrum disorder, obsessive compulsive disorder, alcohol abuse disorder, rhinosinusitis, bronchiolitis, cardiac arrhythmia, and more.

Note that NAC drugs are currently available in generic form since it is off-patent, but a company could bring a new branded NAC drug to market if it was proven effective for an additional indication.

Given these facts, it seems reasonable to assume that the FDA is setting the stage for a new NAC drug to come to market by removing the competition from much cheaper NAC supplements. We called it when the FDA pulled a similar move a few years back when they went after brain health supplements, trying to clear the market for a new Alzheimer’s drug—culminating in the recent approval of an Alzheimer’s treatment that many experts think is not effective. CBD supplements may face a similar fate if Congress does not force the FDA’s hand by legalizing CBD in dietary supplements.

It is critically important to maintain access to affordable NAC supplements. In a recent interview with the Life Extension Foundation, Dr. Daniel Amen noted that NAC “has shown promising results in people with bipolar disorder, schizophrenia, OCD, and addictions. It can also decrease inflammation and may help delay brain atrophy in Alzheimer’s disease.” NAC protects the body from toxins, is a selective immune system enhancer, and helps remove free radicals, which contribute to neurogenerative diseases and aging. In Europe, NAC is a prescription medicine used to reduce congestion.

NAC is also a precursor to glutathione, one of the body’s most important antioxidants. Glutathione plays crucial roles in nutrient metabolism and the regulation of many cellular events (such as gene expression, protein synthesis, cell proliferation, and more); glutathione deficiency contributes to oxidative stress, which is implicated in the development of many diseases: Alzheimer’s, Parkinson’s, liver disease, HIV, heart attack, cancer, stroke, and diabetes.

Note that acetaminophen depletes glutathione, so those who regularly take it should consider, in consultation with an integrative doctor, supplementing with NAC to replenish glutathione levels. In fact, NAC is routinely used in hospitals to counteract acetaminophen toxicity.

NAC is far too important to be threatened by the FDA, especially under such dubious circumstances.

Recently, the FDA announced that, by the end of June 2022, it plans to release drafts or final versions of a number of policies, and among them is the “new dietary ingredient” (NDI) guidance (“new supplement” guidance, in plain English).

It is no exaggeration to say that this is the most dangerous threat to supplements we’ve seen in decades. 

We must continue to vehemently oppose the guidance as currently written and demand that substantial changes are made before the final version is released. It is especially dangerous given that we are in a pandemic situation that is constantly evolving, with scientists warning of viral variants that evade vaccine-induced immunity.

Action Alert! Write to the FDA and tell them not to threaten NAC supplements. Please send your message immediately. 

Wisconsin Physician Fired Over COVID Book

https://www.medpagetoday.com/special-reports/exclusives/93266

Mayo Physician Fired Over COVID Book

— “I’m still in shock I was terminated for this”
A photo of Steven Weiss, MD, and his book: Carnage in America: COVID-19, Racial Injustice, and the Demise of Donald Trump

After publishing a book about his experience on the front lines during the COVID-19 pandemic, a physician was fired from his position at the Mayo Clinic this month, he confirmed to MedPage Today.

Steven Weiss, MD, an internist who practiced at the clinic’s Eau Claire, Wisconsin location for 32 years, stated that he was terminated because he identified himself as an employee of the Mayo Clinic in his new book, called Carnage in America: COVID-19, Racial Injustice, and the Demise of Donald Trump.

According to a June 4 termination letter shared with MedPage Today, Mayo Clinic administrators told Weiss, 62, that his actions violated the health system’s publishing policy, as he did not submit his manuscript to the institution for review before it was printed.

(See link for article)

______________________

**Comment**

You may not like this doctor’s opinion, you may not even agree with it, but the increasing censorship of medical practitioners spells impending doom for free speech & medicine.

This doctor was fired under a “without cause” provision because there was no misconduct, incompetence, negligence, or violation of his employment contract. He simply was fired for not asking “mother may I,” before writing a book on his medical experience.

You can tell by the statements by the administrators that this was all about their fear that people think they support a certain political party.  Weiss discussed the influence of politics, religion, and culture on Americans’ perception of COVID-19, and faulted the administration at the time for the pandemic response.  While there was some negative information on Mayo, Weiss states, “I offered lavish praise in places, too.”

Expect more of this.

Lyme/MSIDS treating doctors have been persecuted for over 40 years due to the fact they disagree with mainstream medicine’s handling of it. Orders in medicine come from the top down and start with the CDC/IDSA‘s abysmal Lyme treatment guidelines that are ineffective, unscientific, and extremely biased.  Wisconsin doctors have come under scrutiny many times for daring to depart from the accepted narrative that Lyme is hard to get and easy to treat.  The reality of thousands of patients proves this to be nothing more than mythology.

Lyme & TBD: Where Are We, 2021?

https://lymediseaseassociation.org/blogs/lda-guest-blogs/kenneth-liegner-md-lyme-tbd-where-we-are-2021/

Kenneth Liegner, MD – Lyme & TBD: Where Are We, 2021?

May Awareness LDA Guest Blogger

Dr. Kenneth Liegner, MD

Dr. Kenneth Liegner is a Board Certified Internist with additional training in Pathology and Critical Care Medicine, practicing in Pawling, New York. He has been actively involved in diagnosis and treatment of Lyme disease and related disorders since 1988. He has published articles on Lyme disease in peer-reviewed scientific journals and has presented poster abstracts and talks at national and international conferences on Lyme disease and other tick borne diseases. He has cared for many persons seriously ill with chronic and neurologic Lyme disease. His work has focused on the serious morbidity and (occasional) mortality that can eventuate from this aspect of the illness. He has emphasized the urgent need for widespread clinical availability of improved methods of diagnostic testing and for development of improved methods of treatment for Lyme disease in all its stages. He holds the first United States patent issued proposing application of acaricide to deer for area-wide control of deer-tick populations as a means of reducing the incidence of Lyme disease. He has authored In the Crucible of Chronic Lyme Disease – Collected Writings & Associated Materials, a documentational history of the struggle to characterize the nature of Lyme disease in the late 20th and early 21st centuries, published November 2015 (www.inthecrucibleofchroniclymedisease.com).

He served two terms on the Board of Directors of The International Lyme and Associated Diseases Society (www.ilads.org), is on the Scientific Advisory Board of the Lyme Disease Association (www.lymediseaseassociation.org), and is a member of the American Medical Association (www.ama-assn.org), the Westchester County Medical Society (www,wcms.org), the Medical Society of the State of New York (www.mssny.org) and The American Association of Physicians and Surgeons (www.aapsonline.org). He is on the staff of Northern Westchester Hospital Center in Mount Kisco, New York (Northwell Health System) and the Sharon Hospital in Sharon, Connecticut (Nuvance Health System).

He was the first physician to apply disulfiram in the treatment of Lyme disease and published his experience with his first three patients in the peer-reviewed journal Antibiotics, May 2019 (https://www.mdpi.com/2079-6382/8/2/72) and reported his first 3 years’ experience with the drug in December 2020 (Antibiotics 2020, 9(12), 868; https://doi.org/10.3390/antibiotics9120868)  He was co-author on a landmark pathologic study of tissues from a person with chronic Lyme disease (https://www.mdpi.com/2079-6382/8/4/183) and co-author of the ILADS evidence-based definition of chronic Lyme disease (https://www.mdpi.com/2079-6382/8/4/269).

Lyme & Tick- & Vector-Borne Disease: Where Are We, May 2021?

The COVID-19 Pandemic has overwhelmed the U.S. of A. and the world and has temporarily overshadowed another ‘shadow on the Land’* – the global pandemic of Lyme disease.

As city denizens flee for more rural areas in efforts to minimize the risks of acquiring COVID-19, they may be less mindful of the risks ticks pose. Deer tick bites often go unnoticed, yet they can transmit the agent of Lyme disease and a range of other infectious diseases:  non-Lyme borrelioses (e.g. tick-borne relapsing fever due to the spirochete Borrelia miyamotoi), Powassan virus, anaplasmosis (a Rocky Mountain Spotted Fever-like illness) and babesiosis. Bartonellosis may also occur in persons with Lyme disease (whether tick- or flea-transmitted or due to a cat scratch), complicating the clinical picture.  Onset of Lyme disease can be insidious and tests not always reliable so there can be delays in diagnosis which allow borrelial infections to become deeply entrenched and more difficult to treat.

The HHS Tick-borne Diseases Working Group with very significant input by patients, advocates and some treating clinicians has developed important perspectives to the problems posed by tick-borne infections and is serving to ‘move things forward’.

Although there has been some increased Federal funding for Lyme and other tick-borne diseases recently, as well as influx of funds from charitable foundations and private donors, the total commitment to solving these complex problems had been inadequate: consistent funding for H.I.V./A.I.D.S. greater than $1 billon/year for decades has enabled real progress in diagnosis and therapy.  An infection that was basically a death sentence is now eminently manageable with oral anti-viral agents. Affected individuals can enjoy a good quality of life with a life-span approximating those not infected.  Annual funding for Lyme disease by comparison, has been paltry.

Sadly, despite decades of advocacy we still lack a clinically available, well-validated and reproducible direct detection test for Lyme disease that can measure ‘borrelial load’ (analogous to measures of ‘viral load’ so very useful in the management of H.I.V./A.I.D.S.).

Likewise, attention to the development of improved therapeutics has been grossly inadequate at the Federal level, progress stymied by the damaging dogma: chronic Lyme disease does not exist.

In the past decade and largely due to funding from private foundations and patient advocacy groups, innovative forays in to repurposing of FDA-approved agents already in the United States Pharmacopeia and novel combinations of pharmaceutical as well has herbal-derived principles in vitro have identified promising new approaches which are beginning to be explored clinically, mostly by individual practitioners.

This ought to be vastly expanded and undertaken as systematic and formal clinical trials against ‘comparator’ agents such as ‘standard’ recommended antibiotherapies.  Such trials are costly, however, would lead to more ‘robust’ data that are more than merely ‘anecdotal’.   This merits funding with Federal dollars.  Academic medical centers are well-equipped and well-accustomed to running such randomized controlled trials.  However, such trials could also be undertaken ‘in the community’ through clinicians actually caring for patients with chronic tick-borne illnesses.

I have likened practitioners caring for patients with the ‘big 3’ B’s of tick and vector-borne diseases (Borreliosis, Babesiosis and Bartonellosis) to playing 3 simultaneous games of chess in 3 dimensions against 3 opposing Grandmasters.  It is a great challenge for practitioners.  It is not boring!  But when one successfully enables patients to improve their quality of life and sometimes (with shared decision-making, luck, skill and patient & practitioner perseverance) to make a full or substantial recovery, well, it is very gratifying.

Lots of work remains to be done!  Let us all resolve to do that work!  Let’s cooperate!  Let’s get busy!

*the title of United States Public Health Service Surgeon General (1936-1948) Thomas Parran’s influential book concerning syphilis

Kenneth B. Liegner, M.D.
Pawling, New York
April 29, 2021

___________________

For more:

Biofilm

https://www.medicalnewstoday.com/articles/319858.php

Strength in numbers: How biofilms outfox antibiotics

Bacteria are vital for survival, but when they form communities, they can wreak serious havoc and pose a threat to our health.

When bacteria flock together and form a community, this is called a biofilm. Found all over the planet — from desert rocks to the surfaces of buildings — biofilms are an integral part of nature.

Biofilms are tricky beasts because they have a tendency to become resistant to all manner of efforts employed to eradicate them. This spells bad news for anyone with conditions such as cystic fibrosisperiodontitis, or chronic wounds as medical implants and catheters are hotspots for biofilm formation.

But why are biofilms so persistent, and what are doctors and scientists doing to outsmart these clever microbial communities?

What are biofilms?

“Biofilms are one of the most widely distributed and successful modes of life on Earth,” says Prof. Hans-Curt Flemming — director of the Institute for Interface Biotechnology at the University of Duisburg-Essen in Germany — in a 2016 article published in Nature Reviews Microbiology.

(See link for article)

_____________________

For more:

Unintended Consequences of COVID Mitigation Efforts – ‘Antimicrobial Resistance’

https://articles.mercola.com/sites/articles/archive/2021/07/21/covid-19-antibiotics-overuse

Surprising Ways COVID-19 Will Destroy Your Immune System

Analysis by Dr. Joseph MercolaFact Checked
covid 19 antibiotics overuse

STORY AT-A-GLANCE

  • The overuse of antibiotics, biocides and disinfectants to fight COVID-19 may “raise disastrous effects” for antimicrobial resistance (AMR)
  • The COVID-19 pandemic has accelerated the spread of AMR, as the majority of patients are treated with antibiotics, despite most not having a bacterial co-infection
  • The excessive and liberal use of antimicrobial products like household and industrial disinfectants, hand sanitizers and other cleaners is raising the risk of AMR in the environment
  • Your mitochondria, which play a role in antibacterial and antiviral immune responses, are an off-site target of certain antibiotics, thus antibiotic therapy may in turn may weaken your immune response
  • With proper “training” at regular intervals denied by COVID lockdowns, your immune system can overreact when triggered by ordinarily harmless substances, leading to allergies and inflammation

Antimicrobial resistance (AMR) has been declared one of the top 10 global public health threats to humanity,1 and it didn’t disappear once the COVID-19 pandemic appeared. Instead, it’s gotten worse, as infection control measures and hand hygiene using antimicrobial gels have become ubiquitous.

AMR causes about 700,000 deaths globally every year, but researchers estimated in mid-2020 that an additional 130,000 AMR deaths would occur in 2020 due to the COVID-19 pandemic.2 

The number of AMR deaths will likely surpass the number of COVID-19 deaths by at least threefold — annually — by 2050,3 with some estimates suggesting AMR deaths may reach as high as 10 million deaths per year.4

Prior to the pandemic, antimicrobial stewardship programs5 had been set up worldwide to help stop the inappropriate use of antimicrobials in hospitals, long-term care facilities and other settings, but a review by scientists with Shahid Beheshti University of Medical Sciences in Iran, published in Frontiers in Microbiology, predicts that an overuse of antibiotics, biocides and disinfectants to fight COVID-19 may “raise disastrous effects.”6 Further, the overuse of antibiotics may also be directly harming immune response.

Antibiotics Given to COVID-19 Patients ‘Just in Case’

Now remember that COVID-19 is caused by the SARS-CoV-2 virus, which means antibiotics are useless against it. Despite this, antibiotics have been used prophylactically throughout the pandemic for COVID-19 patients, typically using the logic that it could prevent bacterial co-infections.

However, the rate of secondary bacterial co-infections has generally been low, while the use of antibiotics has remained high. This isn’t a case of antibiotics being used strategically for patients who develop bacterial infections, but rather using them “just in case.”7 In a study of 38 Michigan hospitals, 56.6% of patients with COVID-19 were given antibiotics early in their stay, but only 3.5% of them turned out to have a bacterial infection.8

“For every patient who eventually tested positive for both SARS-Cov2 and a co-occurring bacterial infection that was present on their arrival, 20 other patients received antibiotics but turned out not to need them,” Dr. Valerie Vaughn, the study’s lead author, said.9 Other studies have revealed similar signs of rampant antibiotic overuse.

In a study of 99 COVID-19 patients in Wuhan, China, 71% received antibiotic treatment, but only 1% had bacterial co-infections.10 Overall, it’s estimated that 1% to 10% of patients with COVID-19 contract a bacterial co-infection,11 yet antibiotics remained a mainstay of treatment for the majority of cases.

Antibiotics Considered ‘Routine’ Part of COVID-19 Treatment

Despite decades of efforts to reduce the unnecessary use of antibiotics, one of the largest studies of antibiotic use in hospitalized COVID-19 patients revealed that such drugs are being used indiscriminately and inappropriately for COVID-19. More than half (52%) of the approximately 5,000 patients included in the study received antibiotics, and in 36% of cases, more than one antibiotic was given.12

Most of the time, in 96% of cases, the antibiotics were given before a bacterial infection was confirmed, either at admission or within the first 48 hours of hospitalization. As it turned out, only 20% ended up actually having a suspected or confirmed bacterial infection for which the antibiotics would be indicated. The rest received them unnecessarily. The Frontiers in Microbiology researchers explained:13

“It is noteworthy to be highlighted that the inappropriate use of antibiotics could considerably and silently lead to AMR development during this global outbreak. Unfortunately, recent studies reveal that, in several countries, common and extensive use of antibiotic treatment for COVID-19 hospitalized patients is considered as a part of the routine treatment package.”

Even the World Health Organization made it clear that countries were at risk of the accelerated spread of AMR due to the COVID-19 pandemic. They cited data showing antibiotic use increased throughout the pandemic. About 79% to 96% of people who reported taking antibiotics didn’t have COVID-19 but were taking them in the hopes of preventing infection, even though antibiotics don’t work against viral infections.14

Antimicrobial Overuse Could Damage Immunity

Antibiotics can cause a number of serious adverse effects, a little-known one being damage to your mitochondria, which are genetically closely linked to bacteria.15 Your mitochondria are responsible for most of your cellular energy production and also play a role in antibacterial and antiviral immune responses — and they’re an off-site target of certain antibiotics,16 which are known to inhibit mitochondrial activity, DNA synthesis and biogenesis.

“Thus, antibiotic therapy could be an important and not well appreciated cause of mitochondrial dysfunction. This in turn may weaken your immune response against the COVID-19 infection,” according to the featured review.17 In April 2020, scientists called for “urgent thinking out of the box” when it comes to antibiotics against COVID-19, as they noted:18

“ … mitochondria are vulnerable to antibacterial treatments, interrupting their physiology. Inhibition of these processes by antibiotics might render the immune system less capable of fighting acute COVID-19 viral infections.”

Concerning Overuse of Biocides and Disinfectants

The COVID-19 pandemic is poised to send antimicrobial-resistant disease sky high, as along with antibiotics overuse came the excessive and liberal use of antimicrobial products like household and industrial disinfectants, hand sanitizers and other cleaners.

The ramifications are immense and only beginning to be understood. There are potential adverse effects to human health from inhaling disinfectants, as such chemicals are known to accumulate in the lungs, liver, kidneys, stomach, brain and blood.19 Exposures were certainly elevated during the pandemic for many people, who were exposed to disinfectants by inhalation and oral routes, as well as via the skin and eyes.

There are also significant environmental concerns due to the “unusual release and dissemination of higher concentrations of biocide-based products into the surface and underground waters and also wastewater treatment systems” during the pandemic.20 When disinfectants and biocides enter the environment, they can wipe out beneficial bacterial species that are keeping drug-resistant microorganisms in check.

“[I]f the biocide concentrations reach the sub-minimum inhibitory concentration (sub-MIC), this event may augment the selective pressure, boost the horizontal gene transfer (HGT), and drive the evolution of AMR,” scientists warn.21

A team from the University of Plymouth in England also conducted a risk assessment to determine the potential environmental impact of prescribing COVID-19 patients antibiotics, which revealed, “The data for amoxicillin indicate a potential environmental concern for selection of AMR … ”22 The team urged such assessments be carried out in the future to keep tabs on the potentially disastrous effects of pandemic prescribing habits on AMR.23

Gut Microbiome Influences Immune Response to COVID

Antibiotics disturb your gut microbiome, which has far-reaching effects on your overall health, including your immune system’s ability to fight COVID-19 — marking yet another way that indiscriminate antibiotics usage is counterproductive.

When researchers with The Chinese University of Hong Kong analyzed gut microbiome compositions from 100 patients with COVID-19, they found gut commensals known to modulate the immune system were low compared to people without the infection.24 The makeup of patients’ gut bacteria — including both the volume and variety — affected the severity of COVID-19 infection as well as the immune response.25

Imbalanced gut microbiome could also contribute to the inflammatory symptoms associated with “long COVID,” in which symptoms persist for months after infection. According to the study:26

“In light of reports that a subset of recovered patients with COVID-19 experience persistent symptoms such as fatigue, dyspnea and joint pains, some over 80 days after initial onset of symptoms, we posit that the dysbiotic gut microbiome could contribute to immune-related health problems post-COVID-19.”

In the study, 50% to 75% of patients received antibiotics, while less than 7% had bacterial infections. While the researchers found no difference in outcomes with or without antibiotics, the drugs were not linked to improved patient outcome and, they noted, “it is still possible that a higher prevalence of antibiotic administration in severe and critical patients could worsen inflammation.”27

Isolation Disturbs Your Immune Response

Of all the negative effects of social isolation endured during the pandemic, those experienced by your immune system may be the last that come to mind, despite being among the most significant for your future health. What does staying home have to do with your immune system?

It alters your 24-hour light/dark cycle, on which your body is built to respond. With more time spent indoors, you have less sunlight exposure and less opportunity to produce vitamin D, which activates macrophages in your lungs that act as a first line defense against respiratory infections, among other immune activities.28

It’s true that taking vitamin D supplements can somewhat compensate for this, provided your levels are optimized, but other ill effects of lockdown are less easily remedied. Take exercise, another crucial component of a well-oiled immune response, that can reduce stress levels and diseases like heart disease and Type 2 diabetes, which are linked to worsened outcomes from COVID-19.

But even beyond that, staying indoors means you lose out on regular exposures to the natural world, which come with their own set of immune benefits. Trees release phytoncides, which people inhale and are known to alter natural killer cells.29 This is why, in Japan, shinrin-yoku, or forest bathing, is said to enhance immune function30 — but it’s difficult to spend much time immersed in the forest if you’re locked down at home.

The other factor that cannot be ignored is the lack of exposure to everyday dirt and germs that is missed when people stay home, socially distanced and sanitized. “Our immune system needs a job,” Dr. Meg Lemon, a Denver dermatologist, told The New York Times. “We evolved over millions of years to have our immune systems under constant assault. Now they don’t have anything to do.”31

What is perhaps most disturbing is that this comment was made in March 2019 — prior to the pandemic. Now, it’s exponentially worse, and your immune system is likely missing out on interactions with bacteria and other microorganisms that teach it, train it how to respond and keep it primed throughout your life.

Without proper “training” at regular intervals, your immune system can overreact when triggered by ordinarily harmless substances, leading to allergies and inflammation. Might a generation of children, kept isolated and masked, have immune repercussions when exposed to ordinarily routine childhood viruses post-pandemic?

Already, cases of respiratory syncytial virus (RSV), which normally circulates in the winter, have popped up in the summer months, suggesting possibly increased immunological susceptibility.32

New Antibiotics Are Unlikely to Save Us

There are 43 antibiotics in clinical development, but none of them shows much promise for solving rapidly rising AMR, as innovation is stagnant — most “new” antibiotics brought to the market are variations of drug classes that have been around since the 1980s. Further, according to WHO’s annual Antibacterial Pipeline Report, antibiotics currently in development are insufficient to tackle AMR:33

“The 2020 report reveals a near static pipeline with only few antibiotics being approved by regulatory agencies in recent years. Most of these agents in development offer limited clinical benefit over existing treatments, with 82% of the recently approved antibiotics being derivatives of existing antibiotic classes with well-established drug-resistance. Therefore, rapid emergence of drug-resistance to these new agents is expected.”

Also at issue, hospital reimbursement systems discourage the use of expensive new antibiotics, because they are only reimbursed up to a point. This means patients may be given older drugs that won’t work as well to protect the hospital from financial losses.

Legislation to reform this — the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act — has been introduced to help open up the use of new targeted antibiotics for superbug infections.34 Preserving the efficacy of existing antibiotics is also important, and agricultural antibiotics overuse cannot be ignored in this equation.

Worldwide, most antibiotics are used not for human illness or companion pets, but for livestock.35 Writing in the International Journal of Antimicrobial Agents, researchers stated, “the ongoing pandemic is stretching the limits of optimal antibiotic stewardship”36 and called for an end to unnecessary use of antimicrobial agents.37

So, be sure you always avoid antibiotics unless they are absolutely necessary. Additionally, choosing organic foods, including grass fed meats and dairy products, can help you avoid exposure to antibiotic residues in the food supply, while also supporting food growers who are not contributing to AMR.

You’ll also want to be careful in your use of disinfectants and sanitizers, using them sparingly and only when truly necessary, which — if you’re outside of a hospital — will be hardly at all.

+ Sources and References
 
Unfortunately what isn’t mentioned is that one of the greatest causes of antibiotic resistance is due to agriculture.
 
While we must certainly be careful in their usage in humans, clinicians were stabbing in the dark in the beginning of COVID to try to determine what would save lives.  Since that time, effective treatments that aren’t antibiotics have been found, but continue to be highly censored by our corrupt public health ‘authorities’, mainstream medicine, and the media, who are nothing more than puppets with severe conflicts of interest.  ‘Authorities’ are even banning natural substances in their efforts to make everyone get the jab.
 
The over usage of extremely toxic chemicals in effort to eradicate germs is truly causing untold damage.  I saw a picture recently of a child who developed horrible rashes on his legs after merely sitting in a grocery cart that had been sprayed and swabbed with these toxic cleaners.  This is new, prevalent, and must stop. 
These cleaners are far worse than a “virus” that has over a 99% survival rate, as well as effective treatments.
The effects of these cleaners will only be determined in time; however, the effects will most probably be pinned on COVID – like everything else.

Go here to listen to James Lyons-Weiler on the toxicity of QUATS.